an open pilot clinical study on Iraippu noi [bronchial asthma]with the evaluation of trial drug thennangal thiravagam
Phase 2
- Conditions
- Health Condition 1: null- patients with symptoms of bronchial asthma
- Registration Number
- CTRI/2014/08/004916
- Lead Sponsor
- government siddha medical college chennai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Cough,Dyspnoea,Chest tightness,Wheeze,
Willing to participate in the trial and sign in the consent form.
Exclusion Criteria
History of congestive cardiac failure.
History of Bronchiectasis.
History of Bronchogenic carcinoma.
History of Chronic bronchitis.
Vulnerable populations like pregnant and lactating women, HIV positive individuals and TB individuals
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is mainly assessed by comparing the peak expiratory flow rate before and after treatmentTimepoint: 30 DAYS
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the safety parameterss before and after treatmentTimepoint: 30 DAYS